NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,477 Cr | ₹1,559 Cr | ₹1,191 Cr | ₹951 Cr | ₹937 Cr |
What is the latest Revenue of NEULAND LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,477 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹1,191 Cr |
| Mar2022 | ₹951 Cr |
| Mar2021 | ₹937 Cr |
How is Revenue of NEULAND LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,477 Cr | -5.24 | |
| Mar2024 | ₹1,559 Cr | 30.84 | |
| Mar2023 | ₹1,191 Cr | 25.25 | |
| Mar2022 | ₹951 Cr | 1.51 | |
| Mar2021 | ₹937 Cr | - | |
Compare Revenue of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,480.1 Cr | -1.3% | -6.3% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.3% |
-6.3% |
12% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses